Menu

Merit Medical Systems, Inc. MMSI

Full chart Compare
Set alert

Price alert · MMSI

All alert types
87.23 USD -2.39 (-2.67%)

At closeNov 6, 2026, 4:05 PM EST

87.23 0.00 0.00%

After hours · Nov 6, 4:05 PM ET

87.05 Day range 88.96
60.31 52-week range 94.20
YTD
-1.03%
1 year
+0.83%
Market cap
5.23B
Revenue (ttm)
1.61B
Profit margin
9.94%
EPS (ttm)
2.67
Shares out
59.92M
P/E ratio
32.67
Forward P/E
18.69
YTD return
-1.03%
1-year return
+0.83%
Volume
354.02K
Avg volume
719.71K
Open
88.33
Previous close
89.62
Day's range
87.05 – 88.96
52-week range
60.31 – 94.20
Beta
0.55
Analysts
Buy
Price target
107.00 (+22.7%)
Earnings date
Feb 23, 2027

5D +1.05 (+1.22%)

8587.5090MonTueWedThuFri87.23

Key statistics

Enterprise value
5.69B
PEG ratio
1.60
Price / sales
3.24
Price / book
3.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
8.40%
Free cash flow
166.63M
Total cash
503.55M
Total debt
822.06M
Return on equity
9.78%
Short % of float
8.55%
50-day average
88.32
200-day average
77.05

Financials — quick view

All financials
MMSI Revenue — quarterly 416.24M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
MMSI Net income — quarterly 42.31M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
MMSI EPS — quarterly 0.71
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

MMSI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20261.11———
Oct 29, 2026Sep 30, 20261.041.12+0.08+7.69%
Jul 30, 2026Jun 30, 20260.9591.19+0.23+24.09%
Apr 30, 2026Mar 31, 20260.840.94+0.10+11.90%
Feb 24, 2026Dec 31, 20250.961.04+0.08+8.33%
Oct 30, 2025Sep 30, 20250.820.92+0.10+12.20%

Upgrades / downgrades

MMSI analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Canaccord GenuitymainBuyBuy
Oct 30, 2026JP MorganmainOverweightOverweight
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 30, 2026NeedhammainBuyBuy
Oct 30, 2026BTIGmainBuyBuy
Oct 27, 2026Freedom Capital Marketsinit—Hold

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
merit.com

News

Your note

Sign in to keep a note on MMSI — it syncs with the Stock Master app.

Insider holders

MMSI insider holders
InsiderRelationLatest transactionDateShares held
ARONSON MARTHA GOLDBERGChief Executive OfficerPurchaseMay 5, 202649,792
CARPENTER LONNY JDirectorStock Award(Grant)May 17, 202620,824
GUNDERSON THOMAS JAMESDirectorConversion of Exercise of derivative securityMay 19, 202660,741
LAMPROPOULOS FRED POfficer and DirectorSaleNov 24, 20251,126,460
LLOYD BRIAN GOfficerStock GiftJun 4, 202662,132
MILLNER F ANNDirectorStock Award(Grant)May 17, 202638,000

Institution ownership

MMSI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.80%9,464,542825.59MJun 29, 2026
Vanguard Portfolio Management LLC5.80%3,473,833303.02MJun 29, 2026
Vanguard Capital Management LLC4.32%2,590,454225.97MJun 29, 2026
State Street Corporation4.13%2,474,512215.85MJun 29, 2026
Dimensional Fund Advisors LP2.76%1,655,196144.38MSep 29, 2026
Geode Capital Management, LLC2.71%1,625,950141.83MJun 29, 2026

Fund ownership

MMSI fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.94%3,556,402310.22MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,802,360157.22MJun 29, 2026
Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund2.58%1,543,773134.66MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.57%1,542,648134.57MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.17%1,299,239113.33MJun 29, 2026
Conestoga Funds-Conestoga Small Cap Fund1.60%958,07583.57MJun 29, 2026